SnusCENTRAL.org is fortunate to have a number of talented writers among our Members. Also deserving to be heard are a number of distinguished authors, scientists, and leaders on the front line fighting for our right to enjoy safer alternatives to cigarettes which deliver nicotine and great taste. Other breaking or notewothy industry news is included here as well.
The release of the Göteborgs Rapé White Stark Portion Snus Limited Edition is significant in three ways. However the flavor is not one of these.
Goteborgs Rapé White Stark (Strong) portion snus is just what it is named; a higher nicotine version of the classic Goteborgs Rapé White. The taste is the same mellow tobacco flavor with notes of juniper, citrus and lavender.
It basically is a limited edition Rapé (150,000 cans)........ Read MORE...
Reporting from a pub somewhere in Sweden, Snus Legend Moe Unz writes about the arrival of the new XRANGE General Salmiak Slim Portion Snus and XRANGE Grov Slim Portion Snus.
Here the story of XRANGE snus and the first 2016 additions to the brand; XRANGE General Salmiak Slim Portion Snus and XRANGE Grov Slim Portion Snus.
He also answers important questions such as what is the flavor difference between licorice and salmiak and can he drink Peter Hagberg from Swedish Match under the table...we all know the answer to the second question.
Click Here to READ MOE'S BLOG POST on XRANGE...
By the time this post is published, I, Moe Unz will be quite full of food, drink and snus. Especially drink. That is why I wrote this 2 days ago during a brief period of sobriety. Hopefully it will turn itself on 1 January 2016 (GMT) so you may read it.
The first quarter of 2016 will be an exciting one for snus lovers around the world (where legal).
It is time for Karolinska, the Public Health Agency and the National Board of Health to do the right thing and explain how there are near zero snus-related negative health issues actually in Sweden. Inform and leave the adults free to make their own health decisions....
Sweden has a unique responsibility to the world to rectify a 40-year old mistakes and potentially save hundreds of millions of lives. It is neither the tobacco itself, or nicotine that kills. It is the fire gases from tobacco smoking, or poor tobacco mixed with other dangerous carcinogens, which kills and destroys health.
When the Unz Family Snus Dynasty launched the new and improved SnusCentral.com Snus Shop website a few months ago, they made the questionable choice of giving Moe Unz his own blog.
Swedish snus legend Moe Unz penned this piece for his blog, Moe Unz: The Blog! He did so prior to New Years Eve since he knew he would be stinking drunk by the time this article published.
You can read Moe's peek into Swedish snus 2015 and other 2015 snus news. It is suprisingly coherent, at least for him.....
Click here to READ New Snus, New Snus Sales, and New Snus Taxes in 2015.
Tobacco Harm Reduction Advocates:
The deadline for FDA comments on Section 918 of the FSPTCA is midnight tonight (I think eastern time). If you haven't already done so, please submit comments to
Suggested NRT, e-cigarette and smokeless tobacco policy recommendations to encourage FDA to implement:
- Keep e-cigarettes and ALL other smokefree tobacco/nicotine products legally accessible and affordable for smokers,
- Approve NRT products for long term and temporary use as a harm reduction substitutes for cigarettes,
- Disapprove FDA approval of NRT for "treating tobacco dependence" because NRT products have >95% failure rate for treating nicotine dependence and for smoking cessation,
- Approve RJ Reynolds' citizen's petition to change the 27 year old deceptive mandatory warning on smokeless tobacco products from "This product is not a safe alternative to cigarettes" to "No tobacco product is safe, but this product presents substantially lower risks to health than cigarettes."
Suggested scientific and educational measures to encourage FDA to adopt and implement:
- Acknowledge that long term use of nicotine poses negligible if any disease risks,
- Acknowledge that all smokefree tobacco/nicotine products (including NRT, smokeless tobacco and electronic cigarettes) are far less hazardous alternatives to cigarettes,
- Acknowledge the mountain of evidence that millions of cigarette smokers have quit smoking and/or sharply reduced cigarette consumption by switching to e-cigarettes, smokeless tobacco products and/or NRT, and
- Correct/clarify all false, misleading and fear mongering propaganda about the health risks of smokeless tobacco products and e-cigarettes at all of the following FDA and DHHS websites:
Executive DirectorSmokefree Pennsylvania1926 Monongahela AvenuePittsburgh, PA 15218412-351-5880
FDA Public Hearing December 17, 2012: FDA Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence
http://www.fda.gov/Drugs/NewsEvents/ucm324938.htm (archived webcasts available)
DA 12/17/12 Hearing: 1 of 4 webcast (FDA's Grail Sipes 0:00-0:08, Gregory Conley 0:08-0:15, Lorie McClung 0:15-0:23, Carl Phillips 0:23-0:39, Linc Williams 0:40-1:00, CASAA's Elaine Keller 1:00-1:14, SRNT's Jonathan Foulds 1:14-1:47)
FDA 12/17/12 Hearing: 2 of 4 webcase (ATTUD's Michael Steinberg 0.00-0.10, CTFK's Danny McGoldrick 0.11-0.17, ACS' Angela Jones 0.18-0.24, Legacy's David Abrams 0.24-1.10, Smokefree Pennsylvania's Bill Godshall 1:11-1:28, TCLC's Kathleen Dachille 1:28-1:37)
FDA 12/17/12 Hearing: 3 of 4 webcast (ACSH's Gil Ross 0:00-0:11, Scott Ballin 0:12-0:22, Altria's James Dillard 0:22-0:37, Johnson & Johnson's James Walmsley 0:38-1:09, GlaxoSmithKline's Howard Marsh 1:09-1:38, What A Smoke's Mark Anton 1:38-1:47)
FDA 12/17/12 Hearing: 4 of 4 webcast (Blue Mist Vaping's Robert Jack 0:00-0:08, American E-Liquid Manufacturing Standards Association's Lou Ritter 0:08-0:32, Legacy's David Abrams 0:33-0:36)
FDA Hearing December 17 - FDA Panel
Grail Sipes (Senior Regulatory Counsel, Office of Regulatory Policy, FDA Center for Drug Evaluation and Research)
Sandra Queer (Deputy Director, Office of New Drugs, FDA Center for Drug Evaluation and Research)
Chistine Wing (Acting Deputy Director, Office of Drug Evaluation, FDA Center for Drug Evaluation and Research)
Bob Rappaport (Director, Division of Anesthesia, Analgesia and Addiction Products, FDA Center for Drug Evaluation and Research)
Lucillia Winchel (Medical Team Leader for Addiction Products, FDA Center for Drug Evaluation and Research)
Andrea Leonard Siegel (Director of Nonprescription Clincial Evaluation, FDA Center for Drug Evaluation and Research)
Corrine Huston (Senior Medical Advisor, FDA Center for Tobacco Products)
Eric Lindblom (Director of Policy, FDA Center for Tobacco Products)
June 4th, 2012 is the deadline to submit comments on FDA's Modified Risk Tobacco Product (MRTP) Application Draft Guidance in which the FDA refused (after being repeatedly urged) to acknowledge that smokeless (or noncombustible) tobacco products are far less hazardous alternatives to cigarettes.
Under the FDA's Draft Guidance for MRTP Applications, it would cost any smokeless tobacco manufacturer (and any e-cigarette manufacturer if the agency "deems" them regulated by Chapter IX, as the agency has repeatedly stated its intent to do) at least $10 million conducting unnecessary research before applying to the FDA to truthfully claim that any of its smokefree tobacco products is less hazardous than cigarettes. Unless the FDA significantly changes its Draft Guidance on MRTP Applications, only several large tobacco companies could even afford to conduct this unnecessary research, and even that would be a very risky investment since the FDA continues to falsely claim "To date, no tobacco products have been scientifically proven to reduce risk of tobacco-related disease, improve safety or cause less harm than other tobacco products,"at the agency's ironically titled "Health Fraud" website on Section 911 and MRTP.
Tweet to @Mr_UNZ
You must be logged into facebook to view this content